Intensity Therapeutics Inc (INTS) Company Sales

Intensity Therapeutics is implementing energy saving and emission filtration in its laboratories to comply with ESG standards. Business stability relies on seamless component logistics from Asia and patent security. High costs for final drug testing are creating financial pressure. The company's sales volume dynamics demonstrate a metric value of 0.00, allowing for an assessment of the model's resilience.

Intensity Therapeutics, Inc. (INTS): Company Revenue from 02/21/2024 to 11/13/2026

Analytical breakdowns for Intensity Therapeutics Inc (INTS)

- stock value and consensus price forecast:

Stock Quotes Intensity Tx|INTS - Price Target Chart

- market capitalization details:

Market Valuation Intensity Therapeutics, Inc.|INTS - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Value per Share Intensity Therapeutics|INTS - Company Book Value|Capitalization to Book Value Ratio intensitytherapeutics.com|INTS - Aggregate Company Assets

- debt obligations and liquidity statistics:

Debt to Capital Intensity Therapeutics|INTS - Long-Term Debt to Equity Ratio|Short-Term Indebtedness to Equity Intensity Tx|INTS - Company Total Debt|Debt to Book Capital Intensity Therapeutics, Inc.|INTS - Company Long-Term Debts|Company Short-Term Loans and Borrowings Intensity Therapeutics|Immediate Liquidity intensitytherapeutics.com

- net income and valuation ratios data:

INTS - Company Net Income|Expected Net Income Intensity Therapeutics|INTS - P/E Multiple|Forward P/E Multiple Intensity Tx|INTS - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Intensity Therapeutics, Inc.|INTS - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Intensity Therapeutics|INTS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months intensitytherapeutics.com|INTS - Earnings per share growth in current year|Projected earnings per share growth rate for next year Intensity Therapeutics

- sales volume and revenue indicators:

INTS - Company Sales|Company Projected Revenue Volume Intensity Tx|INTS - P/S Multiple|Market Cap to Future Revenue Ratio Intensity Therapeutics, Inc.

General company analysis:intensitytherapeutics.com, INTS

Intensity Therapeutics focuses on clinical trials of its oncology platform through narrow alliances with clinics, making revenue dependent on development milestones. This metric aggregates daily cash inflows from the sale of products and services, reflecting the business's operational efficiency. A decline in this value signals liquidity risks and the need for portfolio rebalancing. By analyzing the gross sales volume dynamics of Intensity Therapeutics, an investor can detect stagnation in fundamental indicators in a timely manner.

Key competitors